Arumpanayil Angela
Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA.
Dimens Crit Care Nurs. 2013 Sep-Oct;32(5):229-36. doi: 10.1097/DCC.0b013e3182a076f6.
This article presents a case study demonstrating various rescue therapies considered in the care of a patient with severe, refractory hypoxemia secondary to acute respiratory distress syndrome. In particular, inhaled epoprostenol (Flolan) is becoming an increasingly common alternative to nitric oxide in the treatment of severe, refractory hypoxemia. Research comparing the 2 inhaled vasodilators suggests that epoprostenol is equally efficacious, easier to administer, less costly, and has fewer adverse effects. This article, using a case study approach, discusses the practical implications of this emerging therapy.
本文介绍了一个病例研究，展示了在治疗一名因急性呼吸窘迫综合征继发的严重难治性低氧血症患者时所考虑的各种抢救疗法。特别是，吸入性依前列醇（氟洛兰）在治疗严重难治性低氧血症方面正日益成为一氧化氮的常见替代疗法。比较这两种吸入性血管扩张剂的研究表明，依前列醇同样有效，给药更方便，成本更低，且副作用更少。本文采用病例研究方法，讨论了这种新兴疗法的实际应用。
